Pfizer’s $43B cancer drug acquisition raises suspicion. CEO’s statements hint at broader, ominous implications beyond finance.
NEW ARTICLE: Pfizer completes $43 Billion acquisition of Seagen on Dec.14, 2023 – becomes largest oncology company to treat most TURBO CANCERS caused by mRNA Vaccines – deep dive into the sinister aspects of this very bizarre deal.
Pfizer OVERPAYS $43 billion on small Cancer… pic.twitter.com/ygoHDbVZcE
— William Makis (@MakisMedicine) December 17, 2023